Post-Vaccination Biological Collection
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Mar 12, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how our immune system responds to vaccines. Vaccination is crucial for preventing diseases, but everyone's immune response can be different based on various factors like age, health conditions, and the type of vaccine used. The researchers want to study these responses in different groups of people, especially those with specific health challenges, like patients with immune deficiencies or chronic lung disease, to help improve future vaccines.
To participate in this study, you need to be at least 18 years old, give your consent, and require a vaccination as part of your routine healthcare. Participants will undergo tests that look at how their immune system reacts to vaccines, specifically ones like the flu and pneumonia vaccines. This research aims to gather important information that could enhance vaccine effectiveness for everyone, especially for those in high-risk groups. If you qualify and choose to join, you’ll be contributing to vital research that could benefit many people in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years old
- • Informed and consented
- • Need to be vaccinated for routine care
- Exclusion Criteria:
- • Person under guardianship or safeguards
- • Pregnant or breastfeeding woman
- • No affiliation to a health insurance scheme
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Créteil, , France
Patients applied
Trial Officials
Laetitia Gregoire
Study Chair
APHP URC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials